EPISODE · Apr 24, 2026 · 1 MIN
Rethinking Oral Corticosteroid Therapy for Myasthenia Gravis
from TheBrief.Health · host TheBrief.Health
Oral corticosteroids remain central in myasthenia gravis, but clinicians are shifting toward individualized dosing, combination therapies, and safer long-term strategies to reduce treatment burden and complications.
What this episode covers
Oral corticosteroids remain central in myasthenia gravis, but clinicians are shifting toward individualized dosing, combination therapies, and safer long-term strategies to reduce treatment burden and complications.
NOW PLAYING
Rethinking Oral Corticosteroid Therapy for Myasthenia Gravis
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m